Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A new DPAG-led review paper, published in the journal Brain, has shown that a poorly understood region of the brain called the claustrum may play an important role in how we experience pain.

A representative T2-weighted image of a healthy human brain (red arrows indicate the claustrum) compared with a T2-weighted image showing a lesion reported as affecting the claustrum. © Ishii et al 2011 AJNR, DOI:10.3174/ajnr.A2603 (claustrum lesion)
A healthy human brain (left) and a lesion affecting the claustrum (right). Red arrows indicate the claustrum.

The little understood area of the brain called the claustrum may be the next frontier in improving outcomes for brain damage patients.

A collaboration of Oxford University research groups from DPAG, the Nuffield Department of Clinical Neurosciences (NDCN) and Experimental Psychology (EP) have uncovered new clues regarding the function of one of most densely interconnected, yet rarely studied, areas of the brain.

The researchers reviewed studies of patients with lesions in the claustrum, which although rare show cognitive impairments and seizures. Furthermore, the lack of clinical focus on the claustrum may mean there are many more cases yet to be uncovered.

They also uncovered an underappreciated link between the claustrum and pain. It is already known that there are links between the claustrum and perception, salience and the sleep-wake cycle, but this is the first time a research team has shown how the claustrum might be more involved in the debilitating experience of pain.

Dr Adam Packer, the lead author of the study, said: "The problem with understanding how the claustrum works is that it is deep inside the brain, and damage that is specific to it is a very rare occurrence. What makes it more difficult to work out what the claustrum actually does is that these rare occurrences are also linked to such a broad range of symptoms.

"Clearly, when the claustrum is damaged the effects are severe and better therapies are urgently needed. It is possible that claustrum damage is more common than we currently realise, and it may be a crucial component in many more brain damage cases.

"This work is important because it gives us some insight into the cognitive and neurological processes in which the claustrum may be involved, and gives us targets to pursue in basic research in the lab."

The researchers found several recorded instances of either infection, auto immune, or other process that attacked the claustrum in particular, and by analysing the results of these studies and others the most common symptoms in patients were cognitive impairment and seizures.

More work is required to better understand the claustrum and better understand the impact of damage to the claustrum, which could ultimately change clinical guidelines.

The multidisciplinary team included three first authors Dr Huriye Atilgan (DPAG), Dr Max Doody (DPAG), Dr David Oliver (University of Toronto), Professor Vladyslav Vyazovskiy (DPAG’s sleep PI), Dr Adam Packer (DPAG), Professor Irene Tracey (FMRIB and NDCN), and Associate Professor Sanjay Manohar (EP and NDCN).

More information about the research, including a video interview with Dr Adam Packer, can be found here.

The full paper, ‘Human lesions and animal studies link the claustrum to perception, salience, pain, and sleep’, is available to read in the journal Brain.

This story is also featured on the University of Oxford website.

Similar stories

Mootaz Salman set to target new treatments for stroke

The Chief Scientist Office of the Government of Scotland has awarded a collaborative grant of £298,966 to Dr Mootaz Salman to seek new therapeutic avenues to treat stroke.

New BBSRC grant to further our insights into how the cortex controls sleep

Professor of Sleep Physiology Vladyslav Vyazovskiy and Professor of Developmental Neuroscience Zoltán Molnár have been awarded a Project Grant from the Biotechnology and Biological Sciences Research Council (BBSRC) for “Brain mechanisms of sleep: top-down or bottom-up?”

Raised intracellular chloride levels underlie the effects of tiredness in cortex

A new study, co-authored by Professor Vladyslav Vyazovskiy, published in Nature Neuroscience, has revealed that intracellular chloride levels within cortical pyramidal neurons reflect sleep–wake history.

Key cause of type 2 diabetes uncovered

Research led by Dr Elizabeth Haythorne and Professor Frances Ashcroft reveals high blood glucose reprograms the metabolism of pancreatic beta-cells in diabetes. They have discovered that glucose metabolites, rather than glucose itself, are key to the progression of type 2 diabetes. Glucose metabolites damage pancreatic beta-cell function, so they are unable to release enough of the hormone insulin. Reducing the rate at which glucose is metabolised, and these glucose metabolites build up, can prevent the effects of hyperglycaemia.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.